We have detected that you are using Internet Explorer to visit this website. Internet Explorer is now being phased out by Microsoft. As a result, NHS Digital no longer supports any version of Internet Explorer for our web-based products, as it involves considerable extra effort and expense, which cannot be justified from public funds. Some features on this site will not work. You should use a modern browser such as Edge, Chrome, Firefox, or Safari. If you have difficulty installing or accessing a different browser, contact your IT support team.
Publication, Part of Prescribing Costs in Hospitals and the Community
Hospital Prescribing - England, 2012
Official statistics- Publication Date:
- 13 Nov 2013
- Geographic Coverage:
- England
- Geographical Granularity:
- Regions, Country, Strategic Health Authorities
- Date Range:
- 01 Jan 2012 to 31 Dec 2012
Summary
Please note: on 26 November 2013 an updated version of the report was uploaded to correct an error in the data presented for England in Table 3 of the report. All SHA figures in this table were correct and remain the same. This was due to a production error by the HSCIC.
This report compares expenditure between primary and secondary care in total and for selected areas, including medicines positively appraised by NICE. The specific area covered this year are anti-bacterial drugs (BNF Section 5.1).
Highlights
The overall NHS expenditure on medicines in 2012 was £13.3 billion.
In 2012 hospital use accounted for 36.5 per cent of the total cost, up from 33.3 per cent in 2011.
The cost of medicines rose by 1.5 per cent overall but by 11.1 per cent in hospitals.
Of the drugs positively appraised by NICE, the greatest overall cost was for adalimumab, which also incurred the greatest cost in hospitals.
Resources
Last edited: 27 June 2018 9:08 am